MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Other Accumulated Expenses came in at $2.6 million in Q4 2025, up 191.25% YoY from $903000.0 in Q4 2024, and down 90.69% on a QoQ basis from $28.2 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Other Accumulated Expenses data on file, last reported at $2.6 million in Q4 2025.
- Quarterly Other Accumulated Expenses rose 191.25% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (up 191.25% YoY) and the FY2025 annual result came in at $2.6 million, up 191.25% from the prior year.
- Other Accumulated Expenses declined to $2.6 million in Q4 2025, from $28.2 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $28.2 million in Q3 2025 to a low of $134000.0 in Q2 2021.
- A 5-year average of $2.1 million and a median of $449000.0 in 2021 frame the typical range for Other Accumulated Expenses.
- The widest YoY moves for Other Accumulated Expenses: up 5783.54% in 2025, down 84.71% in 2025.
- Tracing MGTX's Other Accumulated Expenses over 5 years: stood at $456000.0 in 2021, then surged by 104.39% to $932000.0 in 2022, then jumped by 37.12% to $1.3 million in 2023, then dropped by 29.34% to $903000.0 in 2024, then jumped by 191.25% to $2.6 million in 2025.
- The last three Other Accumulated Expenses figures came in at $2.6 million (Q4 2025), $28.2 million (Q3 2025), and $160000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.11 Mn |
| Dec 31, 2025 | 50.28 Mn |
| Sep 30, 2025 | 28.24 Mn |
| Jun 30, 2025 | 6.81 Mn |
| Mar 31, 2025 | 580,000.00 |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 970,000.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | 6.63 Mn |
| Sep 30, 2022 | 3.36 Mn |
| Jun 30, 2022 | 983,000.00 |
| Mar 31, 2022 | 354,000.00 |
| Dec 31, 2021 | 456,000.00 |
| Sep 30, 2021 | 328,000.00 |
| Jun 30, 2021 | 134,000.00 |